83 related articles for article (PubMed ID: 10021301)
1. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.
Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; ten Kate FW; ter Schegget J; Bleker OP
Gynecol Oncol; 1999 Feb; 72(2):199-201. PubMed ID: 10021301
[TBL] [Abstract][Full Text] [Related]
2. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
3. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
4. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.
Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES
J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears.
Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; Lammes FB; ten Kate FW; ter Schegget J; Bleker OP
Cancer; 1996 Jun; 77(12):2538-43. PubMed ID: 8640703
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling.
Finan RR; Irani-Hakime N; Tamim H; Almawi WY
Infect Dis Obstet Gynecol; 2001; 9(2):119-22. PubMed ID: 11495553
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
Schiffman M; Wheeler CM; Castle PE;
J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
[TBL] [Abstract][Full Text] [Related]
8. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
9. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
Apgar BS; Brotzman G
Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
[TBL] [Abstract][Full Text] [Related]
10. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
13. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
14. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
17. [Detection of human papillomavirus types 16, 18 and 33 in exfoliated cervical cells by polymerase chain reaction].
Takahashi Y; Onoe T; Chiba T; Nakamura T; Hayashi Y; Hirose M; Wakuda K; Yamade I; Yamamoto Y; Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1681-6. PubMed ID: 1660508
[TBL] [Abstract][Full Text] [Related]
18. Cytological evaluation and molecular human papillomavirus test of cervical scrapings from women treated for condyloma.
Zehbe I; Strand A; Chua KL; Wilander E
Gynecol Obstet Invest; 1996; 42(2):128-32. PubMed ID: 8878719
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia.
Barlin JN; Bristow RE; Murillo AM; Zahurak M; Veras E; Salani R
J Reprod Med; 2010; 55(3-4):129-33. PubMed ID: 20506673
[TBL] [Abstract][Full Text] [Related]
20. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.
Fife KH; Cramer HM; Schroeder JM; Brown DR
J Med Virol; 2001 Aug; 64(4):550-9. PubMed ID: 11468743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
